Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|October 4, 2021
Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment AnalysisThanh Bach, Gregory A Deye, Ellen E Codd, et al.
The American Journal of Tropical Medicine and Hygiene|June 11, 2008
Case-control study of armadillo contact and Hansen's diseaseBrychan M Clark, Clinton K Murray, Lynn L Horvath, et al.
Research Square|October 4, 2023
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?Gail E Potter, Viviane Callier, Biraj Shrestha, et al.
Malaria Journal|December 20, 2023
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?Gail E Potter, Viviane Callier, Biraj Shrestha, et al.
The American Journal of Tropical Medicine and Hygiene|May 5, 2011
Plasmodium falciparum infection during suppressive prophylaxis with mefloquine does not induce an antibody response to merozoite surface protein-1(42)James E Moon, Gregory A Deye, Lori Miller, et al.
The American Journal of Tropical Medicine and Hygiene|June 6, 2012
Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substancesGregory A Deye, Montip Gettayacamin, Pranee Hansukjariya, et al.
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
Vaccine|January 26, 2021
Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testingDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge modelGregory A Deye, R Scott Miller, Lori Miller, et al.
NPJ Vaccines|November 24, 2025
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccineLisa A Jackson, Rhea N Coler, Gregory A Deye, et al.
Pageof 3